SEC Tracker
Get the app

Eli Lilly LLY

Eli Lilly's Daniel Skovronsky sold shares

Daniel Skovronsky, insider filing for LLY

Form
4
Filed
Importance
Routine
  1. Sold 119 shares on Nov 2, 2026
  2. Owns 159,952.725 shares directly
  3. Owns 72,359 shares through trust
  4. Owns 547 shares through spouse

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Eli Lilly files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Johnson & Johnson JNJ public float $367.0B, Jun 29, 2025
  2. AbbVie ABBV public float $325.1B, Jun 30, 2025
  3. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  4. Merck MRK public float $198.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.